| 10968210 |
Diamino-alkylamino-linked arylsulfonamide compounds with selective activity in voltage-gated sodium channels |
Thomas J. Greshock, James Mulhearn, Anthony J. Roecker, Tianying Jian, Gang Zhou +9 more |
2021-04-06 |
$229,405,000 |
| 10428076 |
Soluble guanylate cyclase stimulators |
Raphaelle Berger, Yi-Heng Chen, Guoqing Li, Joie Garfunkle, Hong Li +9 more |
2019-10-01 |
$149,825,000 |
| 10030027 |
Soluble guanylate cyclase stimulators |
Raphaelle Berger, Yi-Heng Chen, Guoqing Li, Joie Garfunkle, Hong Li +9 more |
2018-07-24 |
$94,643,000 |
| 9365574 |
Soluble guanylate cyclase activators |
Subharekha Raghavan, Cameron Smith, Hong Li, Alan Whitehead, Sherman T. Waddell +12 more |
2016-06-14 |
$59,713,000 |
| 9284301 |
Soluble guanylate cyclase activators |
Darby Schmidt, Subharekha Raghavan, Jian Guo, Jonathan Groeper, Linda Brockunier +4 more |
2016-03-15 |
$52,961,000 |
| 8741910 |
Soluble guanylate cyclase activators |
Linda Brockunier, Jian Guo, Emma R. Parmee, Subharekha Raghavan, Keith Rosauer +1 more |
2014-06-03 |
$91,329,000 |
| 8445538 |
Glucagon receptor antagonist compounds |
Songnian Lin, Xibin Liao, Roman Kats-Kagan, Emma R. Parmee |
2013-05-21 |
$71,313,000 |
| 8436015 |
Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use |
Songnian Lin, Christian P. Stevenson, Emma R. Parmee, Libo Xu, Xibin Liao +3 more |
2013-05-07 |
$67,103,000 |
| 8318760 |
Substituted aryl and heteroaryl derivatives, compositions containing such compounds and methods of use |
Keith Rosauer, Emma R. Parmee, James R. Tata |
2012-11-27 |
$59,805,000 |
| 7968589 |
Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use |
Emma R. Parmee, James R. Tata, Keith Rosauer, Ronald Kim, Amy R. Bittner +2 more |
2011-06-28 |
$60,499,000 |
| 7687534 |
Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use |
Emma R. Parmee, James R. Tata, Keith Rosauer, Ronald Kim, Amy R. Bittner +2 more |
2010-03-30 |
$119,966,000 |
| 7314873 |
(Halo-benzo carbonyl)heterobi cyclic p38 linase inhibiting agents |
James B. Doherty, Swaminathan Natarajan |
2008-01-01 |
|
| 6809199 |
(Halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents |
James B. Doherty, Meng-Hsin Chen, Luping Liu, Julianne A. Hunt, Rowena D. Ruzck +9 more |
2004-10-26 |
$135,161,000 |
